The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 31, 2026
Snapshot (as of Aug 31, 2026): ResMed Inc. (RMD) pays a $2.46 annual dividend ($0.66 quarterly), yielding 1.02% at $240.33/share. Next ex-dividend date 2026-08-20. 12+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.02%
Annual Dividend: $2.46 per share
Payout Ratio: 40.2%
Ex-Dividend Date: 2026-08-20
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 15
ResMed Inc. dividend investors are looking at a medical technology company that makes CPAP devices, ventilators, and cloud-based patient management software like AirView and myAir, serving roughly 140 countries. RMD currently yields 1.02%, with a trailing annual dividend rate of $2.46 per share paid quarterly. The next ex-dividend date is August 20, 2026. At a beta of 0.748, RMD stock moves less than the broader market, which suits investors who prioritize dividend growth over immediate income.
ResMed Inc. pays out 40.2% of earnings as dividends, a payout ratio classified as moderate (40–60%). That level leaves meaningful room to sustain and grow the dividend, supported by a business model that combines recurring demand for respiratory care devices with subscription-style software revenue from platforms like Brightree and MatrixCare. ResMed Inc. dividend safety faces its most credible pressure from any slowdown in the company's two-segment revenue base, particularly if adoption of its SaaS offerings stalls or device reimbursement rates shift.
ResMed Inc. dividend history shows a CAGR of 8.6% per year from 2013 to 2025. The per-share annual dividend grew from $0.84 to $2.26 over that period (2026 is a partial year and excluded from the CAGR calculation). The smallest annual increase in the window was 2.6% in 2020, which sets a floor for what slower growth looks like even in a difficult year.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +9.5% | $1.72 (2022) | $2.26 (2025) |
| 5-Year | +7.7% | $1.56 (2020) | $2.26 (2025) |
| 10-Year | +6.9% | $1.16 (2015) | $2.26 (2025) |
RMD fits growth-and-income investors who want a rising dividend from a medical technology business rather than a high starting yield. The current yield of 1.02% is low (below 2%), and it sits above the 5-year average of 0.79%, meaning the stock is offering slightly more income than it has historically. Twelve consecutive years of dividend increases at an 8.6% annual growth rate is the real draw here. The trade-off is straightforward: investors accept a low current yield in exchange for a dividend that has more than doubled since 2013 and a payout ratio that leaves room to keep growing it.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-20 | $0.6600 |
| 2026-05-14 | $0.6000 |
| 2026-02-12 | $0.6000 |
| 2025-11-13 | $0.6000 |
| 2025-08-14 | $0.6000 |
| 2025-05-08 | $0.5300 |
| 2025-02-13 | $0.5300 |
| 2024-11-07 | $0.5300 |
| 2024-08-15 | $0.5300 |
| 2024-05-08 | $0.4800 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.8600 |
| 2025 | $2.2600 |
| 2024 | $2.0200 |
| 2023 | $1.8400 |
| 2022 | $1.7200 |
Project income from RMD with the RMD dividend calculator or track your full portfolio with the dividend tracker.